Pages that link to "Item:Q3136692"
Jump to navigation
Jump to search
The following pages link to (Q3136692):
Displayed 33 items.
- Secretive processing of the cholinergic form of acetylcholinesterase, its transcriptional activity and involvement in Alzheimer’s disease. (Q3190865) (← links)
- AXON-GLIAL SIGNAGE IN THE BIOLOGY AND PATHOPHYSIOLOGY OF SCHWANN CELLS (Q3191083) (← links)
- Pre and postnatal exposure to environmental pollutants and effect on cognitive and sexual development. Follow-up of the INMA cohort (Q3191572) (← links)
- Treatment at discharge, adherence and clinical results after hip fracture. Population cohort with up to 5 years of follow-up in the National Health System (PREV2FO Study). (Q3191839) (← links)
- Development and validation of a predictive model of risk of osteoporotic fracture at 5 years (Study ESOSVAL-R5). (Q3192439) (← links)
- Exposure to endocrine disruptors and puberty (Q3192450) (← links)
- Cardiovascular Network (Q3192484) (← links)
- Management of schizophrenia in clinical practice. Adequacy, adherence and clinical outcomes (Hospitalisations and Mortality) in a population cohort. (Q3197383) (← links)
- Role of anti-HIV drugs in the onset or progression of non-alcoholic fatty liver disease. (Q3198432) (← links)
- Functional and therapeutic importance of the inflammatory system in the development of hepatic inflammation and hepatocellular carcinoma (Q3198480) (← links)
- Effect of weight loss on endoplasmic reticulum stress markers on morbid obesity: Pathophysiological implications and new therapeutic targets (Q3199947) (← links)
- Role of autophagia and inflammatory in the pathophysiology of obesity: Effect of weight loss and possible therapeutic implications (Q3201038) (← links)
- Validation of miRNAs 15-b-5p, 155-5p and 195-3p as effectors of inflammation and angiogenesis in the diabetic retina: Identification of biomarkers and new therapies (Q3203295) (← links)
- Quality control and traceability of biohazardous medicines (MBP) through the Home Hospital through Big Data models applied to risk analysis. (Q3203335) (← links)
- THEMATIC NETWORK OF COOPERATIVE RESEARCH ON AGEING AND FRAGILITY (RETICEF) (Q3203681) (← links)
- STABILITY, RESILIENCE AND FUNCTIONAL REDUNDANCY OF THE HUMAN INTESTINAL MICROBIOTA DURING DEVELOPMENT AND IN RESPONSE TO ANTIBIOTIC STRESS AND CLOSTRIDIUM DIFFICILE (Q3207520) (← links)
- Allergens and Pharmacists Adverse Reaction Research Network (Q3209466) (← links)
- Platform National Biobank Network (Q3211161) (← links)
- Multicentric study for the search for pre-clinic biomarkers of diabetic retinopathy. Differential expression of micro RNAs in human tears (Q3211230) (← links)
- Design of guides and tools to reduce the impact that adverse events also have on health professionals (second victims) of primary care (coordinated project) (Q3211297) (← links)
- Research Network on Preventive Activities and Health Promotion in Primary Care (Q3211372) (← links)
- Development of a Microorganism Mediated Cardiovascular Risk Diagnostic Test (RICAMM) and Search for Protective Probiotics (Q3212229) (← links)
- Improvement of research infrastructures in personalised medicine for the health application in rare disease and cognitive impairment at the FISABIO Foundation, during the period 2014-2020. (Q3248441) (← links)
- ImplementedImplementation of information systems, evaluation and management of research activity in biomedicine, health and public health, during the period 2014-2020. (Q3249181) (← links)
- Updating of the infrastructures for the incorporation of technological innovation and strengthening of the Valencian Biobanks Network, during the period 2014-2020. (Q3249875) (← links)
- Updating of the infrastructures for processing, quality control and storage of samples in the biobanks of the Valencian Biobanks Network, during the period 2014-2020. (Q3249924) (← links)
- Update of the laboratories of the Antimicrobial Resistance Monitoring Network for the period 2014-2020. (Q3251316) (← links)
- Updating of the infrastructures for research in infectious diseases and emerging epidemics focused especially on its application in public health, during the period 2014-2020. (Q3251899) (← links)
- Interoperability management of biobanks, where the interoperability manager for the Valencian Biobank Network will be developed. (Q3252243) (← links)
- Analytical platform for exposome research, during the period 2014-2020. (Q3252250) (← links)
- CELÉXITA: Connectome-based Knowledge EXtraction for diagnosis and Therapy Evaluation (Q4656690) (← links)
- T-CELBANC: ESTABLISHMENT OF A NATIONAL BANK OF SPECIFIC T LYMPHOCYTES FOR IMMEDIATE USE IN POST-TRANSPLANT OPPORTUNISTIC INFECTIONS (Q4692155) (← links)
- Comprehensive research strategy in SARS-CoV-2 and COVID-19 disease (Q6916608) (← links)